Prime Medicine PRME Unrealized Losses on Investments (Before Tax)
Unrealized Losses on Investments (Before Tax) at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.
The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prime Medicine's unrealized losses on investments (before tax).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Prime Medicine's unrealized losses on investments (before tax)?
- Prime Medicine (PRME) reported unrealized losses on investments (before tax) of $13K in Q1 2026.
- How has Prime Medicine's unrealized losses on investments (before tax) changed year-over-year?
- Prime Medicine's unrealized losses on investments (before tax) decreased by 13.3% year-over-year, from $15K to $13K.
- What is the long-term trend for Prime Medicine's unrealized losses on investments (before tax)?
- Over 3 years (2022 to 2025), Prime Medicine's unrealized losses on investments (before tax) has grown at a -80.2% compound annual growth rate (CAGR), from $384K to $3K.